ECM
BSX icon

ExodusPoint Capital Management’s Boston Scientific BSX Stock Holding History

ExodusPoint Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.57M Buy
+25,000
New +$2M 0.01% 863
2021
Q1 		– Sell
-115,100
Closed -$4.14M – 2136
2020
Q4 		$4.14M Buy
+115,100
New +$4.15M 0.04% 301

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

ExodusPoint Capital Management's BSX Position: Q1 2026 in Review

ExodusPoint Capital Management increased its Boston Scientific (BSX) stake by 81% in Q1 2026, buying an estimated $11.1M and bringing the position to 311,363 shares worth $19.5M. The position accounts for 0.16% of the portfolio, ranked #107.

ExodusPoint Capital Management first reported a position in BSX in Q3 2019 and has held it in 23 quarters since. The position peaked at $84.1M in Q3 2024. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • ExodusPoint Capital Management held 311,363 shares of Boston Scientific worth $19.5M as of Q1 2026.
  • ExodusPoint Capital Management bought 138,963 Boston Scientific shares in Q1 2026, an estimated $11.1M.
  • Boston Scientific made up 0.16% of ExodusPoint Capital Management's portfolio in Q1 2026, its #107 holding.
  • ExodusPoint Capital Management first reported a position in Boston Scientific in Q3 2019 and has held it in 23 quarters since.
  • ExodusPoint Capital Management's Boston Scientific position peaked at $84.1M in Q3 2024.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.